Rituximab and chemotherapy is highly effective in patients with CD20-positive non-Hodgkin's lymphoma and HIV infection [4]

Michele Spina, Joseph A. Sparano, Ulrich Jaeger, Giuseppe Rossi, Umberto Tirelli

Research output: Contribution to journalLetterpeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Rituximab and chemotherapy is highly effective in patients with CD20-positive non-Hodgkin's lymphoma and HIV infection [4]'. Together they form a unique fingerprint.